Table of Content

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. HIV Drugs Market, by Region, 2018-2027 (USD Billion)
1.2.2. HIV Drugs Market, by Medication Class, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global HIV Drugs Market Definition & Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global HIV Drugs Market Dynamics
3.1. HIV Drugs Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global HIV Drugs Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global HIV Drugs Market, by Medication Class
5.1. Market Snapshot
5.2. Global HIV Drugs Market by Medication Class, Performance - Potential Analysis
5.3. Global HIV Drugs Market Estimates & Forecasts by Medication Class, 2017-2027 (USD Billion)
5.4. HIV Drugs Market, Sub Segment Analysis
5.4.1. Multi-class Combination Drugs
5.4.2. Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
5.4.3. Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
5.4.4. Protease Inhibitors (P0Is)
5.4.5. Entry Inhibitors
5.4.6. HIV Integrase Strand Transfer Inhibitors
Chapter 6. Global HIV Drugs Market, Regional Analysis
6.1. HIV Drugs Market, Regional Market Snapshot
6.2. North America HIV Drugs Market
6.2.1. U.S. HIV Drugs Market
6.2.1.1. Medication Class breakdown estimates & forecasts, 2017-2027
6.2.2. Canada HIV Drugs Market
6.3. Europe HIV Drugs Market Snapshot
6.3.1. U.K. HIV Drugs Market
6.3.2. Germany HIV Drugs Market
6.3.3. France HIV Drugs Market
6.3.4. Spain HIV Drugs Market
6.3.5. Italy HIV Drugs Market
6.3.6. Rest of Europe HIV Drugs Market
6.4. Asia-Pacific HIV Drugs Market Snapshot
6.4.1. China HIV Drugs Market
6.4.2. India HIV Drugs Market
6.4.3. Japan HIV Drugs Market
6.4.4. Australia HIV Drugs Market
6.4.5. South Korea HIV Drugs Market
6.4.6. Rest of Asia Pacific HIV Drugs Market
6.5. Latin America HIV Drugs Market Snapshot
6.5.1. Brazil HIV Drugs Market
6.5.2. Mexico HIV Drugs Market
6.6. Rest of The World HIV Drugs Market

Chapter 7. Competitive Intelligence
7.1. Top Market Strategies
7.2. Company Profiles
7.2.1. Boehringer Ingelheim International GmbH
7.2.1.1. Key Information
7.2.1.2. Overview
7.2.1.3. Financial (Subject to Data Availability)
7.2.1.4. Industry Summary
7.2.1.5. Recent Developments
7.2.2. Merck & Co., Inc.
7.2.3. ViiV Healthcare
7.2.4. AbbVie
7.2.5. F. Hoffmann-La Roche Ltd.
7.2.6. Teva Pharmaceutical Industries Ltd.
7.2.7. Bristol-Myers Squibb
7.2.8. Gilead Sciences, Inc.
7.2.9. Johnson & Johnson
7.2.10. Cipla Limited
7.2.11. Daiichi Sankyo
7.2.12. Emcure
7.2.13. Hetero Drugs
7.2.14. Mylan
Chapter 8. Research Process
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes
8.3. Research Assumption



List of Figures


FIG 1. GLOBAL HIV DRUGS MARKET, RESEARCH METHODOLOGY
FIG 2. GLOBAL HIV DRUGS MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. GLOBAL HIV DRUGS MARKET, KEY TRENDS 2019
FIG 5. GLOBAL HIV DRUGS MARKET, GROWTH PROSPECTS 2020-2027
FIG 6. GLOBAL HIV DRUGS MARKET, PORTERS 5 FORCE MODEL
FIG 7. GLOBAL HIV DRUGS MARKET, PEST ANALYSIS
FIG 8. GLOBAL HIV DRUGS MARKET, VALUE CHAIN ANALYSIS
FIG 9. GLOBAL HIV DRUGS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 10. GLOBAL HIV DRUGS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 11. GLOBAL HIV DRUGS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 12. GLOBAL HIV DRUGS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 13. GLOBAL HIV DRUGS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 14. GLOBAL HIV DRUGS MARKET, REGIONAL SNAPSHOT 2017 & 2027
FIG 15. NORTH AMERICA HIV DRUGS MARKET 2017 & 2027 (USD BILLION)
FIG 16. EUROPE HIV DRUGS MARKET 2017 & 2027 (USD BILLION)
FIG 17. ASIA PACIFIC HIV DRUGS MARKET 2017 & 2027 (USD BILLION)
FIG 18. LATIN AMERICA HIV DRUGS MARKET 2017 & 2027 (USD BILLION)
FIG 19. GLOBAL HIV DRUGS MARKET, COMPANY MARKET SHARE ANALYSIS (2019)


List of Tables


TABLE 1. GLOBAL HIV DRUGS MARKET, REPORT SCOPE
TABLE 2. GLOBAL HIV DRUGS MARKET ESTIMATES & FORECASTS BY REGION 2017-2027 (USD BILLION)
TABLE 3. GLOBAL HIV DRUGS MARKET ESTIMATES & FORECASTS BY MEDICATION CLASS 2017-2027 (USD BILLION)
TABLE 4. GLOBAL HIV DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 5. GLOBAL HIV DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 6. GLOBAL HIV DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 7. GLOBAL HIV DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 8. GLOBAL HIV DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 9. GLOBAL HIV DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 10. GLOBAL HIV DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 11. GLOBAL HIV DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 12. GLOBAL HIV DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 13. GLOBAL HIV DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 14. U.S. HIV DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 15. U.S. HIV DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 16. U.S. HIV DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 17. CANADA HIV DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 18. CANADA HIV DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 19. CANADA HIV DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 20. UK HIV DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 21. UK HIV DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 22. UK HIV DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 23. GERMANY HIV DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 24. GERMANY HIV DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 25. GERMANY HIV DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 26. ROE HIV DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 27. ROE HIV DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 28. ROE HIV DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 29. CHINA HIV DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 30. CHINA HIV DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 31. CHINA HIV DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 32. INDIA HIV DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 33. INDIA HIV DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 34. INDIA HIV DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 35. JAPAN HIV DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 36. JAPAN HIV DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 37. JAPAN HIV DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 38. ROAPAC HIV DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 39. ROAPAC HIV DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 40. ROAPAC HIV DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 41. BRAZIL HIV DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 42. BRAZIL HIV DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 43. BRAZIL HIV DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 44. MEXICO HIV DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 45. MEXICO HIV DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 46. MEXICO HIV DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 47. ROLA HIV DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 48. ROLA HIV DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 49. ROLA HIV DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 50. ROW HIV DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 51. ROW HIV DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 52. ROW HIV DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 53. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL HIV DRUGS MARKET
TABLE 54. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL HIV DRUGS MARKET
TABLE 55. YEARS CONSIDERED FOR THE STUDY
TABLE 56. EXCHANGE RATES CONSIDERED